Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
04/2008
04/30/2008CN101168548A Sulfonated compound containing phosphinyl structure and preparation method thereof
04/30/2008CN101168547A Method for synthesizing monomolecular phosphorus-nitrogen expansion type fire retardant
04/30/2008CN100384892C Catalysts for olefin polymerization
04/30/2008CN100384888C Olefin polymerization catalysts, transition metal compounds, processes for olefin polymerization, and alpha-olefin/conjugated diene copolymers
04/30/2008CN100384859C Nucleotide analogs
04/30/2008CN100384820C Phosphate prodrugs of fluorooxindoles
04/29/2008US7365192 Selective hydrolysis of acarbose, acarbose derivatives with trifluoroacetic acid, removing the byproducts, i.e., monosaccharides, disaccharides, and trisaccharides; purifying valienamine in presence of ion-exchange resins
04/29/2008US7365178 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
04/29/2008US7365113 Phosphate ester flame retardants from resorcinol-ketone reaction products
04/29/2008US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX
04/29/2008US7365072 Inhibitors of p38
04/29/2008US7364787 Lysosphingolipid obtained by treating sphingolipid mixture with sphingolipid ceramide N-deacylase for use in improving medicines and enhancing cell and carbohydrate engineering
04/29/2008CA2363317C Novel process for preparing alendronic acid
04/29/2008CA2343002C Ammonia salts of amides of alkylphosphonic acid with ammonium choloride and use as combustion retardant for polymeric materials
04/29/2008CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/29/2008CA2181474C Process for the production of asymmetrical phosphoric acid diesters
04/24/2008WO2008048668A2 Novel inhibitors of chymase
04/24/2008WO2008048394A1 Hydroformylation process
04/24/2008WO2008048128A1 5'-o-[(n-acyl)amidophosphate]- and 5'-o-[(n-acyl)amidothiophosphate]- and 5'-o-[(n-acyl)amidodithiophosphate]- and 5'-o-[(n- acyl)amidoselenophosphate]-derivatives of nucleosides and processes for the manufacture thereof
04/24/2008WO2008047547A1 Novel compound, composition comprising the same, and process for production of polymerizable amide
04/24/2008WO2008046950A1 P,s-type bidentate chiral ligands and use thereof in the pauson-khand reaction
04/24/2008WO2007032028A8 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
04/24/2008US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia
04/24/2008US20080096844 Novel inhibitors of chymase
04/24/2008US20080093980 truxene and isotruxene derivatives, in particular spirotruxene and spiroisotruxene derivatives; use thereof in organic electronic devices, in particular organic electroluminescent devices
04/24/2008CA2665911A1 Hydroformylation process
04/24/2008CA2664612A1 Novel compound, composition comprising the same, and process for production of polymerizable amide
04/23/2008EP1914252A1 Method of polymerization
04/23/2008EP1914237A2 Phosphonate ester antiviral compounds
04/23/2008EP1913151A1 Oxidised phospholipids comprising a fluorophore moiety and use in the determination of the presence of enzymes having antiatherogenetic activity
04/23/2008EP1913009A1 Novel benzimidazole (thio) carbamates with antiparasitic activity and the synthesis thereof
04/23/2008EP1913008A1 Method of preparing phosphonium compound for cyclic olefin polymerization
04/23/2008EP1913007A1 Process for preparing optically active diphosphanes
04/23/2008EP1615935A4 Phosphate derivatives
04/23/2008EP1296992B1 Phosphacyclohexanes and the use thereof in the hydroformylation of olefins
04/23/2008EP1265830B1 Separation of reaction products containing organophosphorus complexes
04/23/2008EP1054875B1 Insecticidal dihydro-oxadiazines, -thiadiazines and -triazines
04/23/2008CN101166747A Ionic liquid containing phosphonium ion and method for producing same
04/23/2008CN101166708A Optically active 3-methylcyclopentadecanone and method for producing intermediate thereof
04/23/2008CN101165064A Oxidation matrix preparation method
04/23/2008CN101165036A Ether compounds, compositions, and uses thereof
04/23/2008CN101164618A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes
04/23/2008CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer
04/23/2008CN100383149C New crystalline Idedate and its composition
04/23/2008CN100383148C Nucleotide analog composition and synthesis method thereof
04/23/2008CN100383116C Methoximinophenylacetic acid amides
04/23/2008CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
04/22/2008US7361786 Polymer enlarged ligands or complexes advantageous in catalytic processes carried out in a membrane reactor; high enantiomeric purity
04/22/2008US7361776 Reacting (eta 6-p-cymene)ruthenium dichloride or ( eta 6-p-cymene)osmium dichloride (II) with ,5-cyclooctadieneor 1,3-cyclohexadiene under reducing condition
04/22/2008US7361761 Process for the preparation of bisphosphonic acid
04/22/2008US7361689 N-amide and haloalkylsulfonyl derivatives of florfenicol; treating or preventing bacterial infections in fish; e.g. 1-(p-fluoromethylsulfonylphenyl)-2-(dichloromethylcarbonylamino)-3-fluoropropanol
04/22/2008US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
04/22/2008US7361647 hydroquinone derivatives of the Geldanamycin family; heat shock protein (chaperone) Hsp90 antagonist; improved solubility and air stability; antiproliferative and anticarcinogenic agents
04/22/2008US7361623 Trimerization of ethylene with a catalyst system comprising a coordination catalyst of a chromium source complexed with a di(alkylphosphinoalkyl)amino ligand, and an alumoxane; improved catalyst selectivity
04/22/2008CA2278130C Group 5 transition metal compounds
04/22/2008CA2210031C Solid phase synthesis of oligonucleotides
04/22/2008CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
04/22/2008CA2162518C Polyether polyamino methylene phosphonates for high ph scale control
04/17/2008WO2008044245A2 A process for the preparation of risedronate sodium hemipentahydrate
04/17/2008WO2008043518A1 Dental adhesive composition
04/17/2008WO2008043499A1 Ethylene diphosphinic acids
04/17/2008WO2008011117A3 Antiviral protease inhibitors
04/17/2008WO2007146085A3 Creatine phosphate prodrugs, compositions and uses thereof
04/17/2008WO2007138381A3 Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections
04/17/2008US20080091050 Process For Producing Phosphonitrilic Acid Ester
04/17/2008US20080091040 Optically active alkenylphosphinic acid ester and process for producing the same
04/17/2008US20080090904 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer
04/17/2008US20080090803 Fatty alcohol drug conjugates
04/17/2008US20080090793 Compounds and methods for the treatment of cancer
04/17/2008US20080090786 Atherosclerosis; ethyl (E)-2-(4-hydroxy-3-methoxyphenyl)vinyl-phosphonofluoridoate; fluorination of organophosphorus compounds, including organothiophosphorus compounds, to form corresponding fluoro(thio)phosphorus compounds
04/17/2008US20080090784 Crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it
04/17/2008US20080090783 LPA Receptor Agonists and Antagonists and Methods of Use
04/17/2008US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs
04/17/2008US20080090781 Formulations Containing Alkylphosphocholines Using Novel Negative Charge Carriers
04/17/2008DE102006048698A1 Ethylendiphosphinsäuren Ethylenediphosphinic
04/17/2008DE102005015605B4 Phosphororganische Verbindungen enthaltende Prepolymere und Verwendungen dafür Organophosphorus compounds containing prepolymers and uses therefor
04/17/2008CA2665572A1 Self etching self priming aqueous dental adhesive composition
04/16/2008EP1911740A1 Potassium channel modulators
04/16/2008EP1911516A1 Homogeneous asymmetric hydrogenation catalyst
04/16/2008EP1911434A1 Dental adhesive composition
04/16/2008EP1910459A1 Fireproof phosphonate product and a method
04/16/2008EP1910388A1 Method for preparing alkoxyamines by photolysis of dithiocarbamates
04/16/2008EP1910387A1 Compounds for preparing immunological adjuvant
04/16/2008EP1910386A2 Diaryl alkylphosphonates and method for preparing same
04/16/2008CN101163710A Phosphine transition metal complex, process for producing the same and anticancer drug containing the same
04/16/2008CN101163709A Process for the manufacture of aminoalkylenephosphonic acid compounds in the presence of a heterogeneous catalyst
04/16/2008CN101163708A Process for the manufacture of aminopolyalkylenephosphonic acid compounds
04/16/2008CN101163661A Method for purifying quaternary onium salts
04/16/2008CN101163549A Processes for recovery of a triarylphosphine from a group viii metal catalyst complex mixture
04/16/2008CN101161661A Method for purifying 2'-hydroxy biphenyl-2-phosphinic acid
04/16/2008CN101161660A Method for preparing and purifying high-purity O,S-dimethyl thiophosphoryl amide
04/16/2008CN101161659A Method for preparing tetraphenyl diphenol A diphosphonate
04/16/2008CN101161658A Method for manufacturing powder bisphenol A di(biphenyl phosphate)
04/16/2008CN100381451C C2-symmetrical chirality bis ruthenium ligand and its synthesis method
04/16/2008CN100381442C Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives
04/15/2008USRE40245 Gyrase inhibitors and uses thereof
04/15/2008US7358365 Process for the controlled increase in the molecular weight of polyethylenes
04/15/2008US7358363 Zinc complexes capable of capturing substances having anionic substituents
04/15/2008US7358361 Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases